Pfizer looks to spin off cream of Japan lab
85851
Pfizer Inc , the world's largest drug maker, said on Friday it is in talks with investors about spinning off its Japanese research and development laboratory, albeit as a much smaller organization.
722145
Will Pfizer be able to offset the looming loss of Lipitor?
374108
Drug giant Novartis AG says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made.
217275
In the cold, calculating world of Wall Street, that&#39;s how the unfolding drama of new test results on old drugs is playing out, as analysts see bright spots for Pfizer (PFE:NYSE - news - research) amid other drugs&#39; woes.
445497
Pfizer said that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.
485764
With the sudden failure of torcetrapib, Pfizer Inc.'s most important experimental product, financial analysts predict shares of the world's largest drugmaker could fall from 5 to 25 percent on Monday and that Pfizer will need to buy other products to fill the void.
326752
Pfizer plans to ask for approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
640990
Now might be a great time to load up on cutting-edge drug makers.
738382
The drug maker is poised to speed past its rivals.
223134
NEW YORK - Pharmaceutical giant Pfizer Inc. reiterated Tuesday it would meet its 2004 earnings target but said over the next two years it would lose $14 billion in revenues because of patent expirations.
443190
A conglomerate of Japanese companies hopes to develop biochips.
190069
The FDA issues a health advisory for a top Pfizer drug.
241106
Hoffman-La Roche Inc., the US prescription pharmaceuticals unit of Swiss drug maker Roche Group, said Thursday that it will jointly develop and market an asthma drug with biotechnology firm Protein Design Labs Inc.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
145081
For a small biopharmaceutical firm that has yet to get a drug on the market, Medarex Inc. has been keeping some impressive company. Top pharmaceutical and biotech firms, from Johnson &amp; Johnson to Amgen Inc., have been signing deals with Medarex to use its genetically engineered mice as they seek to develop new drugs. The doctored mice have the rare ability to produce human antibodies, which can help fight disease just as natural antibodies do.
717110
The Japanese retailer eyes acquisitions to spur U.S. growth.